Ultra Vires Acts
Definition of 'Ultra Vires Acts'Any act that lies beyond the authority of a corporation to perform. Ultra Vires acts fall outside the powers that are specifically listed in a corporate charter or state law. They can also be any action that is specifically prohibited by the corporate charter. |
|
Investopedia explains 'Ultra Vires Acts'Ultra Vires acts can also be defined as any excessive use of corporate power that has been granted. These acts cannot be legally defended in court. They will, in fact, leave the corporation vulnerable to lawsuits by employees or other parties. |
Related Definitions
Articles Of Interest
-
Should You Incorporate Your Business?
Find out how becoming a corporation can protect and further your finances. -
Whom Should Corporations Please?
Companies balance the interests of owners, customers and employees. Find out who comes out on top. -
The Basics Of Corporate Structure
CEOs, CFOs, presidents and vice presidents: learn how to tell the difference. -
Corporate Takeover Defense: A Shareholder's Perspective
Find out the strategies corporations use to protect themselves from unwanted acquisitions. -
Can a corporation deduct dividend payments to shareholders before taxes are calculated?
Corporations may not legally deduct the dividend payments before taxes but there is another approach - a corporate structure called an income trust. Income trusts allow a firm to deduct dividends, ... -
Top 4 Most Scandalous Insider Trading Debacles
Here we look at some of the landmark incidents of insider trading. -
Handcuffs And Smoking Guns: The Criminal Elements Of Wall Street
From godfathers to perps, familiarize yourself with the "criminal elements" creeping around Wall Street. -
Defining Illegal Insider Trading
The better you understand why insider trading can be criminal, the better you'll understand how the market works. -
Digging For Profitable Delistings
Deregistration can provide opportunities for savvy investors. We'll show you how to cash in. -
Big Pharma Faces 'Pay For Delay' Lawsuits
Unless you follow the pharmaceutical and biotech sectors, it’s likely that you’ve never heard of pay to delay. Instead of planning to lose nearly all revenue once the drug goes off patent, the ...
Free Annual Reports